Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ophthalmos is a Brazilian pharmaceutical company specializing in the development, manufacturing, and commercialization of ophthalmic products. Founded in 1989, the company provides a wide range of therapeutic solutions including eye drops, ointments, and diagnostic agents for conditions such as glaucoma, infections, and inflammatory ocular diseases. Ophthalmos operates a specialized manufacturing facility in São Paulo that adheres to Good Manufacturing Practices (GMP) to supply the domestic healthcare market and surgical centers. The company is recognized for its focus on eye health and its extensive portfolio of generic and branded ophthalmic medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ophthalmos Pharmaceutical Industry.